Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging strategies, clinical trial design, regulatory planning, analytical and clinical assay validation, fda submission services, and custom clinical gmp kit manufacturing. Its technologies comprise next generation sequencing, droplet digital pcr, qpcr, rt-qpcr, allele-specific pcr, sanger sequencing, capillary electrophoresis fragment analysis, immunohistochemistry, hematoxylin and eosin staining, and digital imaging. MMD's clinical trails services include centralized clinical testing, clinical trial assay and IVD development, advanced diagnostics, and manufacturing commercialization. The company serves the biopharma’s needs for clinical trial assays and clinical trial services. It operates offices in Oregon and Massachusetts, the US. MMD is headquartered in Portland, Oregon, the US. MolecularMD Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on... Research Beam Model: Research Beam Product ID: 2637713 250 USD New
MolecularMD Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

MolecularMD Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : October   2017
  • Pages : 19
  • Publisher : GlobalData
 
 
 
Summary

MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging strategies, clinical trial design, regulatory planning, analytical and clinical assay validation, fda submission services, and custom clinical gmp kit manufacturing. Its technologies comprise next generation sequencing, droplet digital pcr, qpcr, rt-qpcr, allele-specific pcr, sanger sequencing, capillary electrophoresis fragment analysis, immunohistochemistry, hematoxylin and eosin staining, and digital imaging. MMD's clinical trails services include centralized clinical testing, clinical trial assay and IVD development, advanced diagnostics, and manufacturing commercialization. The company serves the biopharma’s needs for clinical trial assays and clinical trial services. It operates offices in Oregon and Massachusetts, the US. MMD is headquartered in Portland, Oregon, the US.

MolecularMD Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MolecularMD Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MolecularMD Corp, Medical Devices Deals, 2011 to YTD 2017 9
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MolecularMD Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
Partnerships 14
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 14
MolecularMD Corp - Key Competitors 15
MolecularMD Corp - Key Employees 16
MolecularMD Corp - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Legal and Regulatory 18
Jun 01, 2017: MolecularMD achieves status as an ArcherDX Certified Service Provider and expands offering of novel NGS chemistries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
MolecularMD Corp, Pharmaceuticals & Healthcare, Key Facts 2
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MolecularMD Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MolecularMD Corp, Deals By Therapy Area, 2011 to YTD 2017 8
MolecularMD Corp, Medical Devices Deals, 2011 to YTD 2017 9
MolecularMD Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 14
MolecularMD Corp, Key Competitors 15
MolecularMD Corp, Key Employees 16
MolecularMD Corp, Other Locations 17
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter